Logo Logo

Category Archives: "News"

  1. Home
  2. INforMS
  3. Page 5
Apr 28, 2021
Phase 1/2 study to evaluate the safety and efficacy of ATA188 in progressive multiple sclerosis
INforMS
The purpose of this study is to evaluate the safety and tolerability of ATA188 as a monotherapy in Parts 1 and 2, to determine the [...]
Elizabeth Porco
Read More
...16
0
Apr 16, 2021
New data for Ocrevus disease progression (ocrelizumab) reinforce significant slowing
INforMS, Partners
– 85% of treatment-naïve, early-stage relapsing-remitting multiple sclerosis (RRMS) patients achieved no evidence of disease activity [...]
Elizabeth Porco
Read More
...15
0
Apr 07, 2021
New Genentech data at 2021 AAN highlight impact & breadth of neuroscience portfolio
INforMS, Partners
Evrysdi (risdiplam) 2-year FIREFISH Part 2 data show improvement in motor function in infants with Type 1 spinal muscular atrophy [...]
Elizabeth Porco
Read More
...17
0
Mar 19, 2021
Janssen announces U.S. FDA approval of PONVORY™ (ponesimod)
INforMS, Partners
Head-to-head pivotal clinical trial results showed PONVORY™ treatment led to nearly a third fewer annual relapses than [...]
Elizabeth Porco
Read More
...15
0
Mar 08, 2021
NeurologyLive® & the CMSC launches MS Cure Connections® Video Series
CMSC PR, Partners
A diverse panel including an expert neurologist, a psychologist, a patient, and a care partner discuss the patient's journey with [...]
Elizabeth Porco
Read More
...19
0
Feb 02, 2021
FDA approval of intramuscular Plegridy (Peginterferon beta-1a)
INforMS, Partners
Please be advised  of the recent approval by the FDA for intramuscular Plegridy (Peginterferon beta-1a) and an update to other sections [...]
Elizabeth Porco
Read More
...16
0
Dec 09, 2020
Dr. Thrower discusses management, different types of multiple sclerosis fatigue
INforMS
https://youtu.be/vtwauNrp8Jo Ben Thrower, MD, Medical Director, Andrew C. Carlos Multiple Sclerosis Institute, talks about different [...]
Elizabeth Porco
Read More
...16
0
Oct 01, 2020
NeurologyLive® and CMSC partner to present two expert-driven webcast programs
CMSC PR
NeurologyLive®, a multimedia platform dedicated to providing health care professionals who treat neurological diseases with direct access [...]
Elizabeth Porco
Read More
...18
0
Sep 11, 2020
New data further reinforce Genentech’s Ocrevus (ocrelizumab) as effective treatment
INforMS
7 5% of patients with relapsing-remitting multiple sclerosis (RRMS) and suboptimal response to prior treatment had no evidence of disease [...]
Elizabeth Porco
Read More
...15
0
Aug 24, 2020
Genentech’s enspryng for Neuromyelitis Optica Spectrum Disorder
INforMS, Partners
First and only FDA-approved subcutaneous treatment option for anti-aquaporin-4 antibody positive NMOSD that can be self-administered by a [...]
Elizabeth Porco
Read More
...17
0
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last

Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM